Evidence map›Paper›PMID 30964372›Full record

SynthesisHuman vaccines & immunotherapeutics2019

Systematic review of the rotavirus infection burden in the WHO-EMRO region.

Selim Badur, Serdar Öztürk, Priya Pereira, Mohammad AbdelGhany, Mansour Khalaf, Youness Lagoubi, Onur Ozudogru, Kashif Hanif, Debasish Saha

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Human vaccines & immunotherapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Observational
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Selim BadurMENA, Medical & Clinical Emerging Markets, GSK, Istanbul, Turkey.
Serdar ÖztürkMENA, Medical & Clinical Emerging Markets, GSK, Istanbul, Turkey.
Priya PereiraGlobal Medical Affairs Rota/MMRV, GSK, Wavre, Belgium.ORCID 0000-0001-7344-310X
Mohammad AbdelGhanyEM Central Vaccines Medical/Clinical, GSK, Cairo, Egypt.
Mansour KhalafEM Central Vaccines Medical/Clinical, GSK, Jeddah, Saudi Arabia.
Youness LagoubiEM Central Vaccines Medical/Clinical, GSK, Casablanca, Morocco.
Onur OzudogruEM Central Vaccines Medical/Clinical, GSK, Dubai, United Arab Emirates.
Kashif HanifEM Central Vaccines Medical/Clinical, GSK, Karachi, Pakistan.
Debasish SahaEpidemiology/Health Economics EM, GSK, Wavre, Belgium.
Central Laboratory For Agricultural Expert Systems · EGDubai Medical College · AEUniversity of Jeddah · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rotavirus gastroenteritis imposes a heavy burden on low- and middle-income countries. The World Health Organization defines the Eastern Mediterranean region (WHO-EMRO) as a diverse area in terms of socioeconomic status and health indicators. Rotavirus vaccination has been introduced, at least partially, in 19 out of the 22 EM countries; however, vaccine coverage remains low, and data on rotavirus disease burden is scarce.Available data on rotavirus prevalence, seasonality, vaccination status, and genotype evolution was systematically compiled following a literature review that identified 165 relevant WHO-EMRO epidemiology studies published between 1990 and 2017.Although the infectious agents responsible for acute gastroenteritis vary over time, rotavirus remained the leading cause of acute gastroenteritis in children, as seen in 76.3% of reviewed publications. Younger children (<2 years old) were at higher risk and thus increased vaccination coverage and surveillance systems are required to reduce the rotavirus gastroenteritis burden in WHO-EMRO countries.

Indexed as

Child, PreschoolCost of IllnessGastroenteritisGeographyHospitalizationHumansInfantMediterranean RegionPrevalenceRotavirusRotavirus InfectionsRotavirus VaccinesVaccination CoverageWorld Health OrganizationRotavirus VaccinesburdenchildrenEastern Mediterranean regiongastroenteritisincidenceRotavirus

Identifiers

PMID30964372
PMCPMC6930073
OpenAlexW2937756849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.